drugset / Trial / NCT00918957
A Study of Tobramycin Inhalation Powder From a Modified Manufacturing Process Versus Placebo
RandomizedParallel-groupTriple-blindTreatment
Summary
This study is designed to show how well tobramycin inhalation powder works and how safe it is when produced by a modified manufacturing process
Timeline
- Start
- 2009-06
- Primary completion
- 2011-05
- Completion
- 2011-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Tobramycin | Small molecule | 112 mg | Inhaled |